The main treatment methods of liver cancer include surgical resection,TACE,ablation,immunotherapy and liver transplantation,etc.Ablation promotes the death of liver cancer cells to achieve the purpose of anti-tumor.Immunotherapy can reactivate immune cells and generate new immune responses through corresponding pathways,so as to recognize and eliminate liver cancer cells.Combining ablation can synergistically enhance anti-tumor immune effect of immunotherapy for liver cancer.The research progresses of ablation combined with immunotherapy for liver cancer were reviewed in this article.

The main treatment methods of liver cancer include surgical resection,TACE,ablation,immunotherapy and liver transplantation,etc.Ablation promotes the death of liver cancer cells to achieve the purpose of anti-tumor.Immunotherapy can reactivate immune cells and generate new immune responses through corresponding pathways,so as to recognize and eliminate liver cancer cells.Combining ablation can synergistically enhance anti-tumor immune effect of immunotherapy for liver cancer.The research progresses of ablation combined with immunotherapy for liver cancer were reviewed in this article.

Objective:To investigate the related factors affecting intraoperative blood loss in patients with spinal tumors undergoing preoperative selective arterial embolization.Methods:The clinical data of 90 patients with spinal tumors who underwent preoperative selective arterial embolization in the Affiliated Hospital of Jining Medical College and the Second Affiliated Hospital of Shanxi Medical University from January 2017 to December 2020 were retrospectively analyzed. The influencing factors of intraoperative bleeding were analyzed by using multiple linear regression.Results:There were statistically significant differences in intraoperative blood loss of spinal tumor patients undergoing preoperative selective arterial embolization with different blood supply abundance and the number of tumors involving vertebral body (all P < 0.05). There were no significant differences in age, gender, body mass index, interval after embolization, operation time, pathological type, tumor site, embolization degree, the number of embolized vessels, preoperative Frankel grade among different groups (all P > 0.05). Multiple linear regression analysis showed that the number of tumors involving vertebral body and tumor blood supply abundance were factors affecting intraoperative blood loss, and vertebra number and tumor blood supply were positively correlated with intraoperative blood loss (all P < 0.05). Conclusion:For patients with spinal tumors undergoing preoperative selective arterial embolization, the number of tumors involving vertebral body and the abundance of the tumor blood supply are factors affecting the amount of intraoperative bleeding.